Quarterly report pursuant to Section 13 or 15(d)

Non-Controlling Interests (Tables)

v3.23.3
Non-Controlling Interests (Tables)
9 Months Ended
Sep. 30, 2023
Non-Controlling Interests  
Schedule of Non-Controlling Interests in Consolidated Entities

​

​

​

​

​

​

​

​

​

​

​

For the Nine Months Ended

    

    

​

    

    

 

​

September 30, 2023

​

As of September 30, 2023

​

​

 

​

Net loss attributable to

​

Non-controlling interests

​

Non-controlling

 

($ in thousands)

non-controlling interests

​

in consolidated entities

​

ownership

 

Avenue1

 

(9,298)

​

 

(3,346)

 

88.3

%

Cellvation

 

(25)

​

 

(1,949)

 

21.3

%

Checkpoint2

 

(26,625)

​

 

(16,966)

 

89.1

%

Coronado SO

 

—

​

 

(290)

 

13.0

%

Cyprium

 

(1,335)

​

 

(5,491)

 

28.3

%

Helocyte

 

45

​

 

(5,994)

 

17.5

%

JMC2

 

(515)

​

 

8,035

 

46.2

%

Mustang1

 

(34,026)

​

 

3,184

 

79.4

%

Oncogenuity

 

(11)

​

 

(1,721)

 

27.0

%

Urica

$

(2,022)

​

$

(5,379)

 

33.0

%

Total

$

(73,812)

​

$

(29,917)

 

  

​

​

​

​

​

​

​

​

​

​

​

​

For the Year Ended

​

    

​

​

    

 

​

December 31, 2022

​

As of December 31, 2022

​

​

 

​

Net loss attributable to 

​

Non-controlling interests 

​

Non-controlling 

 

($ in thousands)

non-controlling interests

    

 in consolidated entities

    

 ownership

 

Aevitas3

 

(425)

​

 

(5,753)

 

45.2

%

Avenue1

 

(2,355)

​

 

3,054

 

89.9

%

Baergic4

 

(113)

​

 

—

 

—

%

Cellvation

 

(102)

​

 

(1,791)

 

21.3

%

Checkpoint2

 

(48,406)

​

 

(16,008)

 

82.2

%

Coronado SO

 

—

​

 

(291)

 

13.0

%

Cyprium

 

(1,173)

​

 

(3,817)

 

29.0

%

Helocyte

 

(122)

​

 

(5,900)

 

17.9

%

JMC2

 

(12,458)

​

 

7,429

 

43.7

%

Mustang1

 

(60,821)

​

 

37,640

 

81.3

%

Oncogenuity

 

(111)

​

 

(1,575)

 

27.4

%

Tamid5

 

(1)

​

 

(776)

 

22.8

%

Urica

$

(1,251)

​

$

(3,908)

 

40.2

%

Total

$

(127,338)

​

$

8,304

 

​

​

​

Note 1:

Avenue and Mustang are consolidated with Fortress’ operations because Fortress maintains voting control through its ownership of Class A Preferred Shares which provide super-majority voting rights.

Note 2:

Checkpoint and JMC are consolidated with Fortress’ operations because Fortress maintains voting control through its ownership of Class A Common Shares which provide super-majority voting rights.

Note 3:  Effective April 21, 2023, Aevitas ceased to be a controlled Fortress entity and as such is no longer consolidated (see Note 3, Asset Purchase Agreements).

Note 4:  Fortress’ ownership in Baergic was transferred to Avenue as of November 7, 2022 (see Note 15, Related Party Transactions).

Note 5:  Tamid was dissolved in the quarter ended September 30, 2023.